Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WBF-038 for Bone Loss Prevention in Breast Cancer Patients on Aromatase Inhibitors
NCT07044310Phase 2Recruiting
- Sponsor
- Mayo Clinic
- Start
- Jul 2025
- Primary completion
- Jul 2027
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Pendulum Glucose Control in osteoporosis, sponsored by Mayo Clinic. Started Jul 2025; status: recruiting.
02
Drugs
Pendulum Glucose Control
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT07044310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07044310.